nivolumab
bms
['remain trial', 'leukemia', 'nivo', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'nivolumab']
#ash22 #leusm liu: relapses 68% in nivo arm (n=38) vs 71% in observation arm (n=41). no diff in pfs. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)